Needham Reiterates Buy Rating on Veracyte (VCYT)

January 12, 2026 5:59 AM UTC Send to a Friend
Needham analyst Mike Matson reiterated a Buy rating and $44.00 price target on Veracyte (NASDAQ: VCYT).The analyst commented: "On Sunday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login